|

HX301+/Temozolomide Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Hangzhou Hanx Biopharmaceuticals, Ltd.1

Indications

  • Glioma1
  • Cancer1

Other1 trial

A Phase 2 Study of HX301 in Patients with High-grade Giloma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.